Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
43000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
Who receives how much
43,000 shares (number of shares delivered during the relevant month: 43,000 new shares and 0 treasury shares transferred)
EVO FUND (the allotment recipient of these stock acquisition rights issued on 4 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
The exercise price during the relevant month ranged from ¥463 to ¥476. Details of the adjustment provisions and the adjustment floor are Not disclosed
Number of Stock Acquisition Rights
Total number issued: 10,000; unexercised at the end of the month preceding the relevant month: 7,830; unexercised at the end of the relevant month: 7,400
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 4 December 2025 / Type 18th Series of Stock Acquisition Rights, with provisions for adjustment of the exercise price and suspension of exercise, allotted to EVO FUND / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | 43,000 shares (number of shares delivered during the relevant month: 43,000 new shares and 0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allotment recipient of these stock acquisition rights issued on 4 December 2025) |
| Exercise price | The exercise price during the relevant month ranged from ¥463 to ¥476. Details of the adjustment provisions and the adjustment floor are Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 10,000; unexercised at the end of the month preceding the relevant month: 7,830; unexercised at the end of the relevant month: 7,400 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 4 December 2025 / Type 18th Series of Stock Acquisition Rights, with provisions for adjustment of the exercise price and suspension of exercise, allotted to EVO FUND / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.